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Summary. The myenteric plexus of the gastrointestinal 
tract was investigated in the obese diabetic mouse, an 
animal model of human type 2 diabetes. Sections were 
immunostained by the avidin-biotin complex method, 
using a general nerve marker, protein gene product 9.5 
(PGP 9.5), as well as antibodies to several important 
neurotransmitters. Computerized image analysis was 
used for quantification. When diabetic mice were 
compared with controls, no difference was found in the 
density of PGP 9.5-immunoreactive (IR) nerve fibres in 
antrum, duodenum or colon. In antrum and duodenum, 
diabetic mice showed a decreased number of vasoactive 
intestinal peptide (V1P)-IR neurons in myenteric ganglia 
as well a decreased relative volume density in myenteric 
plexus (though not significantly in antrum, p=0.073). No 
difference was found regarding VIP-IR nerves in colon. 
The volume density of nitric oxide synthase (NOS)-IR 
nerve fibres was decreased in antrum and duodenum of 
diabetic mice, whereas no difference was found in colon. 
The density of galanin-IR neme fibres was decreased in 
duodenum. Whereas neuropeptide Y (NPY)- and 
vesicular acetylcholine transporter (VAChT)-IR nerve 
fibres was increased in density in colon of diabetic mice, 
no difference was found in antrum and duodenum. 
Regarding substance P, there was no difference between 
diabetic and control mice in antrum, duodenum or colon. 
The present study shows that gut innervation is affected 
in this animal model of human type 2 diabetes. It is 
possible that the present findings may have some 
relevance for the gastrointestinal dysfunctions seen in 
patients with type 2 diabetes. 
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lntroduction 
Patients with type 1 or type 2 diabetes often show 
complications in the gastrointestinal tract, such as 
Offprint requests to: Magdy El-Salhy, MD PhD, Section for 
Gastroenterology and Hepatology, Department of Medicine, University 
Hospital, S-901 85 Umeii, Sweden. Fax: +46-90-143986. e-rnail: 
rnagdy.el-salhy@medicin.umu.se 
gastroparesis,  constipation, diarrhoea and faecal 
incontinence (Bargen et al., 1936; Kassander, 1958; 
Feldman and Schiller, 1983; Locke 111, 1995). As  
extrinsic and intrinsic nerves of the gastrointestinal tract 
are important regulators of gut functions, such as 
motility, secretion and absorption (Allescher et al., 1991; 
Ekblad et al., 1991; Rangachari, 1991; Costa and 
Brookes, 1994), it is possible that changes in these may 
occur and be involved in the pathogenesis of the 
gastrointestinal symptoms observed in diabetes patients. 
To study gut innervation, however, transmural biopsies 
are needed, which are difficult to obtain from diabetes 
patients. Thus, animal models of diabetes are often used 
to study possible disturbances in the diabetic state. In 
both genetically- and chemically-induced animal models 
of diabetes type 1, several disturbances in the enteric 
innervation of the gut have been reported (Ballman and 
Conlon, 1985; Belai et al., 1985, 1991; Service et al., 
1985; Loesch et al., 1986; Di Giulio et al., 1989; Wrzos 
et al., 1997; El-Salhy and SpAngeus, 1998a; SpAngeus 
and El-Salhy, 1998a; SpAngeus et al., 2000). In contrast, 
there are only a few published studies on the enteric 
innervation in animal models of diabetes type 2 (Baily et 
al., 1986; El-Salhy, 1998). The relation of changes in 
neurotransmitters and the gastrointestinal dysfunction is 
not established. 
The present study was undertaken to investigate the 
myenteric plexus in different segments of the 
gastrointestinal tract of a genetically prone, type 2 
diabetes animal model,  namely the oblob-mouse 
(Herberg and Coleman, 1977; Lord and Atkins, 1985). 
Thus antrum, duodenum and colon were studied as to 
represent stomach, small and large intestine. In this 
study the myenteric plexus was investigated with a 
general nerve marker, namely protein gene product 9.5, 
PGP 9.5 (Krammer et al., 1993, 1994), as well as for 
several important neurotransmitters of the gut, known to 
regulate motility and secretion. 
Material and methods 
Seven 20-week-old, male homozygous obese (oblob) 
diabetic mice (UmeAIBom-ob, Bomholtgird Breeding 
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and Research Centre, Ry, Denmark) were investigated. 
They were compared with 7 non-diabetic age-matched 
male homozygous lean (+/+) control mice 
(Bomholtgird). The animals were kept 5 to each cage in 
an artificially lit room (12h/12h, lightldark) and were fed 
standard pellet diet (Astra-Ewos AB, Sodertalje,  
Sweden) and water ad libitum. They were housed in our 
vivarium for  one week to adapt them to the new 
conditions prior to killing. After overnight starvation, the 
animals were killed in a C02  chamber and about 1 cm 
long specimens of the antrum, proximal duodenum and 
dista1 colon were excised. Data on the animals were 
obtained from the supplier: for the diabetic mice, body 
weight was 101.522.7 g, plasma glucose 11.620.3 
mmollliter and plasma insulin 24.027.4 ng/ml (mean 2 
SEM). The corresponding figures for the lean control 
mice were 42.210.6 g, 7.410.4 mmol/liter and 2.350.5 
ng/ml. The local committee on animal ethics at Umei 
University approved the investigation. 
lmmunocytochemistry 
Tissues were fixed overnight, without applying any 
tension, in 4% buffered formaldehyde. They were 
embedded in paraffin wax and cut into 10  pm-thick 
transversal sect ions (i .e.  perpendicular to the 
longitudinal muscle layer). After pre-treatment with 
microwave antigen retrieval to unmask epitopes, the 
sections were immunostained according the avidin-biotin 
complex (ABC) method (Dakopatts,  Glostrup, 
Denmark), as described in detail elsewhere (Nyhlin et 
al., 1997). In brief, after hydration the sections were 
treated in a microwave oven (650 W) for three 5-min 
cycles, each cycle in fresh 0.01M citrate buffer (pH 6.0). 
Endogenous peroxidase was inhibited by treatment with 
0.5 m1 Hs02 (30%) in 50 m1 Tris buffer for 10 min, and 
non-specific binding sites were blocked with 1% bovine 
serum albumin for 10 min. The primary antiserum was 
applied to the sections overnight in a moist chamber, 
followed by incubation with the secondary antibody 
(biotinylated swine anti-rabbit, diluted 1:200) for 30 
min. Avidin-biotin-peroxidase complex (diluted 1:50) 
was applied to the sections for 60 min. Al1 incubations 
were at room temperature. Finally, sections were placed 
for 10 min in a 50 m1 Tris buffer containing 25 mg 3,3- 
Table 1. Pnmary antisera used. 
diamino-benzidine tetrahydrochloride (DAB) and 10 m1 
H202  (30%) to detect peroxidase, followed by slight 
counter-staining with Mayer's haematoxylin. Data on the 
primary antisera are presented in Table 1. 
Specificity controls were performed as described 
previously (El-Salhy et al., 1993). Briefly, they included 
positive controls from human antrum, duodenum and 
colon, as well as  paravertebral ganglia from mice. 
Furthermore, staining was performed after replacing the 
primary antibody with non-immune rabbit serum as well 
as  after pre-incubating the primary antibody with 
corresponding or structurally related peptides. Thus 
NPY antibodies were pre-incubated with PYY and PP, 
VIP antibodies with GIP, glucagon, secretin, PHI and 
CCK, substance P antibodies with neurokinin A, and 
galanin antibodies with CCK-39, VIP and secretin. 
Computerized image analysis 
Immunoreactive nerves were quantified as described 
earlier (El-Salhy et al., 1997). Briefly, a Quantimet 
500MC image processing and analysis system (Leica, 
Cambridge, England) was connected to an Olympus 
microscope (type BX50), and was run with QWIN 
(version 1.02, Leica), a computerized image analysis 
program together with QUIPS (version 1.02, Leica), an 
interactive programming system. Quantifications were 
performed with x4, x20 and x40 objectives, where each 
pixel of the computer image corresponded to 2.12, 0.414 
and 0.206 pm, respectively, and each field represented a 
tissue area of 1.3,0.04 and 0.009 mm2, respectively. 
The relative volume density of nerve fibres in 
muscularis propria was quantified in an automated 
standard analysis sequence according to the classical 
stereological point-counting method (Weibel and Elias, 
1967; Weibel et al., 1969) as adapted for computerized 
image analysis (El-Salhy et al., 1997; El-Salhy and 
Spangéus, 1998a). Briefly, a 400-point lattice was 
superimposed on the frame covering muscularis propria. 
Al1 points not covering muscularis propria were 
manually erased by using the computer 'mouse'. Points 
covering immunostained nerve fibres were marked, and 
a ratio of points covering nerve fibres and muscle tissue 
was tabulated. Measurements were performed in 20 
randomly chosen fields (from 2-4 different sections, 150 
ANTIGEN* DlLUTlON 
Protein gene product 9.5 (PGP 9.5) 
Synthetic substance P 
Porcine vasoactive intestinal peptide WlP) 
Synthetic neuropeptide Y (NPY) 
Synthetic galanin 1-29 
Synthetic rat vesicular acetylcholine transporter (VAChT)§ 
Hurnan neurona1 nitric oxide synthase (nNOS) 
Bovine dopamine-B-hydroxylase 
CODE 
RA 951 O1 
B 069082 
R 7854101 -85 
R 840403/B6 
R 841 8061B2 
R 9WB28-1 
N 31 030 
360 PESO2 
SOURCE 
Ultra Cione Ltd., England 
BioGenex Laboratories, USA 
Eurodiagnostica, Sweden 
Eurodiagnostica 
Euro-diagnostica 
Euro-diagnostica 
Transduction Laboratories, Denmark 
Chemicon lnternational Inc., USA 
*: al1 the anüsera were raised in rabbit; 5: speciíic for Gterminal 
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pm apart) for each mouse and for each neme fibre type. 
The  number of immunoreactive neurons in 
myenteric ganglia was measured using the tool kit from 
the manual menu. The immunolabelled neurons in the 
ganglion were counted manually, followed by 
measurement of ganglion area by drawing around the 
ganglion with the computer 'mouse' .  From each 
gastrointestinal segment, ten ganglia per animal and 
neurotransmitter were randomly selected and measured. 
The number of myenteric ganglia per mm baseline 
of muscularis propria was measured using the x4  
objective and tools from the manual menu. Three 
sections from each mouse were measured by drawing a 
line parallel to the rnuscle layer and counting the number 
of ganglia. Ganglion area was measured by drawing a 
line around the ganglion, using the x20 objective. For 
each mouse, 15 randomly-chosen ganglia were measured 
(from 2-4 different sections, 150 pm apart). 
Thickness of muscularis propria was measured under 
the x20 objective, using the manual menu, as described 
earlier (Spingéus and El-Salhy, 1998b). Briefly, in each 
mouse and each gastrointestinal segment, four fields 
were chosen at random, and in  each field 15 
perpendicular lines were drawn through the muscularis 
propria. 
Statistical analysis 
Comparisons between diabetic and control mice 
were performed with the non-parametric, Wilcoxon 
(Mann-Whitney) test.  P-values below 0.05 were 
considered significant. 
<F 
Results 
Immunocytochemistry 
Antrum, duodenum and colon of both diabetic and 
control mice showed nerve fibres immunoreactive to 
PGP 9.5, substance P, VIP, NPY, galanin, VAChT and 
Fig. 1. Relative volume density of protein gene product 9.5- 
immunoreactive nerve fibres in the muscularis propria of antrum, 
proximal duodenum and distal colon of diabetic and control mice (mean 
I SEM). 
NOS. Dopamine-8-hydroxylase-IR nerve fibres were 
seldom encountered in the myenteric plexus of gut, and 
no further quantification was made. Nerve fibres of all 
bioactive substances investigated were evenly distributed 
within muscularis propria. Whereas PGP 9.5,  substance 
P-, VIP-, NPY-, galanin- and NOS-IR neurons were 
detected in the myenteric ganglia, no VAChT-IR neurons 
could be detected. 
The antisera used in the present study immuno- 
stained nerve elements  in  human gut  a s  well a s  
dopamine-B-hydroxylase in paravertebral ganglia from 
mice. No immunostaining was detected when the 
primary antisera were pre-incubated with the 
corresponding bioactive substance or when the antisera 
were replaced by non-immune rabbit serum. Pre- 
Flg. 2. Relative volume density of immunoreactive nerve fibres in the 
muscularis propria of antnim, proximal duodenum and distal colon of 
diabetic and control mice (mean i SEM). VIP: vasoactive intestinal 
peptide; NPY: neuropeptide Y; NOS: nitric oxide synthase; *: p<0.05; 
": p<o.o1. 
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incubation of primary antibody with structurally related 
peptides did not affect the immunostaining. 
Computerized image analysis 
The relative volume density of nerve fibres in 
muscularis propria and of neurons in myenteric ganglia 
is illustrated in Figs. 1-3. 
Antrum 
No difference was found between control and 
diabetic oblob mice regarding PGP 9.5-IR nerve fibres. 
Diabetic mice showed a decreased relative volume 
density of NOS-IR as well as a tendency to have a 
decreased density of VIP-IR nerve fibres (p=0.0728). No 
difference was found regarding substance P-, NPY-, 
galanin- and VAChT-IR nerve fibres. The number of 
Flg. 3. lmmunoreactive neurons per mm2 of myenteric ganglia in 
antrum, proximal duodenum and dlstal colon of diabetic and control 
mice (meaniSEM). Abbreviations and symbols as in Fi 2. 
VIP-IR neuronslganglionic area was significantly lower 
in myenteric ganglia from diabetic mice than in the 
controls (Fig. 4). No difference was found regarding 
substance P-, NPY-, galanin- and NOS-IR neuronsl 
ganglionic area. 
Duodenum 
Density of PGP 9.5-IR nerve fibres did not differ 
between the two groups. Diabetic mice showed a 
signiñcantly decreased volume density of VIP- (Fig. 4), 
NOS- and galanin-IR nerve fibres. No difference was 
found between diabetic and control mice regarding 
density of substance P-, NPY- and VAChT-IR nerve 
fibres. There was a decreased number of VIP-IR 
neuronslganglionic area as well as a tendency to have a 
decreased number of NOS-IR @=0.0530) neuronsl 
ganglionic area in myenteric ganglia of diabetic mice, 
compared with controls. No difference was found in the 
numbers of substance P-, NPY- and galanin-IR 
neurons/ganglionic area. 
Colon 
No difference was found regarding PGP 9.5-IR 
nerve fibres. In diabetic mice there was a significantly 
increased volume density of NPY- and VAChT-IR nerve 
fibres. No difference was found regarding substance P-, 
VIP-, galanin- and NOS-IR nerve fibres. There was a 
tendency to have a decreased number of galanin-IR 
neurons/ganglionic area in myenteric plexus @=0.0530). 
No difference was found regarding substance P-, VIP-, 
NPY- and NOS-IR neuronslganglionic area. 
There was no difference between diabetic oblob 
mice and lean controls regarding number of ganglia per 
mm baseline of muscularis propria, or of ganglion area, 
in antrum, duodenum and colon. Nor was there any 
difference regarding the thickness of muscularis propria 
in antrum, proximal duodenum and dista1 colon (Table 
2). 
Table 2. Morphometric measurements of muscularis propria thickness 
and of rnyenteric ganglia (mean~SEM). 
CONTROL DlABETlC P VALUE 
MlCE MlCE 
Antrum 
Muscularis propria @m) 
Ganglion area (mmq 
Ganglion density* 
Duodenum 
Muscularis propria @m) 
Ganglion area (mmq 
Ganglion density* 
Colon 
Muscularis propria @m) 
Ganglion area (mmq 
Ganglion density* 
*: number of ganglia per mm of longitudinal muscle. 
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FIg. 4. VIP-immunoreactive nerve fibres in the 
duodenal muscularis propiSa of a coRtrol mame (A) 
and of a diabetic oblob mouse (B). V1P-immuno- 
reactive neurons in antral myenteric gangllon of a 
control mouse (C) and of a diabetic oblob rnouse (DI. 
x 420 
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Discussion 
The present investigation revealed abnormalities of 
severa1 neurotransmitters in the neurons of myenteric 
plexus and nerve fibres of muscularis propria in obese 
(ob/ob) diabetic mice, an animal model of human type 2 
diabetes. These abnormalities were found in al1 parts of 
gut investigated, namely the antrum, duodenum and 
colon. The  nature of these abnormalities varied, 
however, between different segments of the gastro- 
intestinal tract. Thus, whereas there was a decrease in 
some neurotransmitters in the upper gastrointestinal 
tract,  there was mostly an increase in the lower 
gastrointestinal tract. 
Although nerve fibres immunoreactive to severa1 
neurotransmitters were decreased in muscularis propria 
of the antrum and duodenum of diabetic mice, the total 
amount of nerve fibres as detected by PGP 9.5 did not 
differ from that of controls. This might be due to 
unchanged or increased neme fibres of neurotransmitters 
not investigated here. 
The decreased number of VIP-IR neurons/ganglionic 
area in myenteric ganglia and decreased relative fibre 
volume density in the myenteric plexus in antrum of 
diabetic mice observed here tallies with results of 
radioimmunoassays, RIA, reported earlier (El-Salhy, 
1998). The present finding of a decreased number and 
density of VIP-IR nerves in duodenum, as well as an 
unaltered number and density in colon, disagrees with 
previously reported observations that the VIP content 
was unaltered or even increased in small intestine, and 
was decreased in colon of animal models of type 2 
diabetes (Baily et al., 1986; El-Salhy, 1998). In type 1 
diabetes animal models, changes in VIPergic innervation 
have been reported, though the nature and extent of these 
varies between different studies (Ballman and Conlon, 
1985; Service et al., 1985; Loesch et al., 1986; El-Salhy 
and Spangéus, 1998b; Di Giulio et al., 1989; Belai et al., 
1991; Spangéus et al., 2000). Thus, both the chemically- 
induced and the genetically-prone diabetes states seem 
to affect VIP-IR nerves of the gut. 
NOS-IR nerve fibres showed a decreased relative 
volume density in both antrum and duodenum of 
diabetic mice. Furthermore, the number of NOS-IR 
neurons showed a tendency to decrease in duodenum. 
Similarly, there was a decreased number of NOS-IR 
neurons in the myenteric ganglia of the duodenum of 
non-obese diabetic (NOD) mice, a type 1 diabetes model 
(Spangéus et al., 2000). However, the NOD mice as well 
as BB/W rats, another type 1 diabetes model, also 
showed a decreased number of antral NOS-IR neurons 
of myenteric ganglia (Takahashi et al., 1997; Wrzos et 
al., 1997; Spangéus et al., 2000). As NOS is found in 
enteric inhibitor motor neurons (McConalogue and 
Furness, 1994), it is possible that the changes found in 
these diabetic animal models may affect gut motility. 
The present study showed an increased volume 
density of VAChT-IR neme fibres in the colon, but an 
unchanged density in antrum and duodenum. This is in 
contrast to previous observations made in type 1 diabetes 
models, which showed a decreased colonic acetylcholine 
content,  but an increased content in antrum and 
duodenum (Schmidt et al., 1981; Spangéus et al., 2000). 
The present finding of an increased density of NPY- 
IR fibres in the colon of diabetic mice is in contrast to 
earlier RIA studies on ob/ob mice, where a decreased 
content of colonic NPY was found (El-Salhy, 1998). 
This discrepancy may be due to the fact that in the 
earlier study (El-Salhy, 1998) NPY was measured in 
extraction of whole-wall biopsies, whereas the present 
study investigated nerve fibres exclusively in muscularis 
propria. 
The tendency to have a decreased number of colonic 
galanin-IR neurons in myenteric ganglia is in agreement 
with a previously obsewed decreased galanin content in 
colon (El-Salhy, 1998). 
The present study shows that the neurotransmitter 
homeostasis is affected in an animal model of human 
type 2 diabetes. It is possible that the present findings 
may have some relevance for the gastrointestinal 
dysfunctions seen in patients with type 2 diabetes. 
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